September 4, 2017 / 8:12 AM / 22 days ago

BRIEF-Taho Pharmaceuticals receives patent in US

Sept 4(Reuters) - Taho Pharmaceuticals Ltd :

* Says it received patent for oral solution comprising atomoxetine hydrochloride and methods thereof in US

Source text in Chinese: goo.gl/XpmC9e

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below